Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Peter Voorhees received his medical degree from the University of Michigan. He continued his postgraduate studies with an internal medicine residency/chief residency at the University of Wisconsin, and a hematology-oncology fellowship at the University of North Carolina at Chapel Hill. Dr. Voorhees is Director of Outreach for Hematologic Malignancies, Plasma Cells Disorder Program, Department of Hematologic Oncology and Blood Disorders at Levine Cancer Institute, Charlotte, North Carolina. He was previously an assistant professor in the Department of Internal Medicine, Division of Hematology-Oncology, at the University of North Carolina at Chapel Hill.
Dr. Voorhees is board certified in hematology and internal medicine. His research focuses on the development of novel therapeutic strategies for the treatment of multiple myeloma. He is also interested in the basis of chemotherapy-related toxicity and the development of tools that predict for adverse events with treatment.